FLSM
RETA

Frazier Life Sciences Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Frazier Life Sciences Management’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-100,430
Closed -$10.2M – 55
2023
Q2 		$10.2M Buy
+100,430
New +$9.5M 0.61% 31

Other funds holding RETA

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return